Medical-Office Volume Jumps 34% as Portfolios Trade

The Signal:

• Medical office is being treated as need-based, recession-insulated income at scale.
• The action is portfolio and platform level, not one-off buildings.

Medical-office investment volume topped 14 billion dollars, up about 34 percent year over year, with portfolio deals near 7 billion dollars. Welltower is selling its MOB portfolio to Remedy Medical Properties, and Catalyst Healthcare Real Estate and Nuveen formed a 400 million dollar equity joint venture backing about 1.3 billion dollars of development.

Medical office is doing what senior housing is doing one sector over, attracting capital that wants demographic tailwind without cyclicality. Outpatient care volume rises with an aging population regardless of the macro, and the rent roll of health systems and physician groups on long leases underwrites cleanly.

A 34 percent jump in volume with 7 billion dollars in portfolio trades says institutions are building or exiting scale, not dabbling. Welltower selling to Remedy and the Catalyst and Nuveen development JV are two sides of the same conviction.

For CRE readers, the edge is health-system credit and campus adjacency, not the MOB label itself.

Implications: For owners, portfolio liquidity has returned to well-leased, near-campus product. For developers, a 400 million dollar equity JV signals new outpatient supply is financeable again. For investors, tenant credit and location relative to the anchor hospital are the whole underwrite.